Trial Profile
A Phase III, Randomized, Open, Parallel-controlled, Multi-center Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary) ; Cyclophosphamide; Prednisone
- Indications Lupus nephritis
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 24 Sep 2018 Status changed from active, no longer recruiting to completed.
- 11 Jul 2018 Planned End Date changed from 1 Jun 2018 to 1 Sep 2018.
- 11 Jul 2018 Planned primary completion date changed from 1 Jun 2018 to 1 Sep 2018.